Table 1.
Characteristics of Prostate Cancer Patients by Treatment Received, 1999–2011
| Surgery
|
Radiotherapy
|
p | |
|---|---|---|---|
| n (%) | n (%) | ||
| Total | 17440 | 14672 | |
| Follow-up time(years) | |||
| Median (IQR) | 4.79(2.60–7.29) | 4.54(2.51–6.98) | <0.01 |
| Range | 0.09–11.91 | 0.09–11.95 | |
| Age at diagnosis(years) | |||
| Median (IQR) | 69 (67–72) | 73 (69–76) | |
| 66–69 | 9559(54.8) | 3774(25.7) | <0.01 |
| 70–74 | 6327(36.3) | 5587(38.1) | |
| 75–79 | 1316(7.5) | 3971(27.1) | |
| 80–84 | 199(1.1) | 1155(7.87) | |
| 85+ | 39(0.2) | 185(1.26) | |
| Race | |||
| White | 15442(88.5) | 12375(84.3) | <0.01 |
| Black | 1119(6.4) | 1427(9.73) | |
| Other | 879(5.0) | 870(5.93) | |
| Year of diagnosis | |||
| 1999–2001 | 2013(11.5) | 1613(11.0) | 0.05 |
| 2002–2004 | 3094(17.7) | 2720(18.5) | |
| 2005–2007 | 4781(27.4) | 4121(28.1) | |
| 2008–2011 | 7552(43.3) | 6218(42.4) | |
| Elixhauser score, excluding anemia | |||
| 0 | 11744(67.3) | 7949(54.2) | <0.01 |
| 1 | 3950(22.6) | 3918(26.7) | |
| 2+ | 1746(10.0) | 2805(19.1) | |
| Anemia | |||
| No | 17085(98.0) | 14250(97.1) | <0.01 |
| Yes | 355(2.0) | 422(2.9) | |
| Stage | |||
| I | 10391(59.6) | 9566(65.2) | <0.01 |
| II–III | 7049 (40.4) | 5106 (34.8) | |
Abbreviation: IQR, interquartile range.